Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 47.65
-0.25 (-0.52%)
Jun 18, 2026, 2:58 PM CST
TPEX:6864 Market Cap
TPEX:6864 has a market cap or net worth of 1.55 billion as of June 18, 2026. Its market cap has decreased by -49.92% in one year.
Market Cap
1.55B
Enterprise Value
1.36B
Revenue
612.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
47.65
Market Cap Chart
Since December 29, 2021, TPEX:6864's market cap has increased from 1.50B to 1.55B, an increase of 3.35%. That is a compound annual growth rate of 0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.55B | -44.72% |
| Dec 31, 2025 | 2.80B | 42.37% |
| Dec 31, 2024 | 1.97B | 210.82% |
| Dec 29, 2023 | 633.75M | -17.29% |
| Dec 30, 2022 | 766.25M | -45.27% |
| Dec 30, 2021 | 1.40B | -6.67% |
| Dec 29, 2021 | 1.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunny Pharmtech | 1.97B |
| 3D Global Biotech | 1.92B |
| Greenyn Biotechnology | 1.82B |
| Synbio Tech | 1.68B |
| Great Novel Therapeutics Biotech & Medicals | 1.63B |
| TaiRx | 1.63B |
| NeoCore Technology | 1.49B |
| Advagene Biopharma | 1.47B |